Skip to main content
SpringerLink
Log in

The fading role of triple therapy in patients with atrial fibrillation and acute coronary syndrome: a Bayesian network meta-analysis

  • Letter to the Editor
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, Ellinor PT, Ezekowitz MD, Field ME, Furie KL, Heidenreich PA (2019) AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the american college of Cardiology/American heart association task force on clinical practice guidelines and the heart rhythm society. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2019.01.011.

    Article  PubMed  Google Scholar 

  2. Cannon CP, Bhatt DL, Oldgren J, Lip GYH, Ellis SG, Kimura T et al (2017) Dual antithrombotic therapy with dabigatran after PCI in atrial fibrillation. N Engl J Med 377(16):1513–1524

    Article  CAS  PubMed  Google Scholar 

  3. Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman JP et al (2013) Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet (London, England) 381(9872):1107–1115

    Article  CAS  Google Scholar 

  4. Gibson CM, Mehran R, Bode C, Halperin J, Verheugt F, Wildgoose P et al (2015) An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention (PIONEER AF-PCI). Am Heart J 169(4):472-8.e5

    Article  CAS  PubMed  Google Scholar 

  5. Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH (2019) Antithrombotic therapy after acute coronary syndrome or PCI in atrial fibrillation. New Engl J Med 380(16):1509–1524

    Article  CAS  PubMed  Google Scholar 

  6. Lip GY, Collet JP, Haude M, Byrne R, Chung EH, Fauchier L, Halvorsen S, Lau D, Lopez-Cabanillas N, Lettino M, Marin (2019) 2018 joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA). Europace 21(2):192–193

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, West Virginia University School of Medicine, 1 Medical Center Drive, Morgantown, WV, 26506, USA

    Mohammed Osman, Muhammad Bilal Munir, Jason A. Moreland & Sudarshan Balla

  2. Hurley Medical Center, Michigan State University, Flint, MI, USA

    Babikir Kheiri

  3. Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, USA

    Samir Kapadia

Authors
  1. Mohammed Osman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Babikir Kheiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Muhammad Bilal Munir
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jason A. Moreland
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sudarshan Balla
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Samir Kapadia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammed Osman.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Osman, M., Kheiri, B., Munir, M.B. et al. The fading role of triple therapy in patients with atrial fibrillation and acute coronary syndrome: a Bayesian network meta-analysis. J Thromb Thrombolysis 48, 516–518 (2019). https://doi.org/10.1007/s11239-019-01896-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-019-01896-9

Search

Navigation